Yost Capital Management LP Buys New Position in Molina Healthcare, Inc $MOH

Yost Capital Management LP bought a new stake in shares of Molina Healthcare, Inc (NYSE:MOHFree Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 30,000 shares of the company’s stock, valued at approximately $5,206,000. Molina Healthcare accounts for 7.6% of Yost Capital Management LP’s investment portfolio, making the stock its 8th biggest position.

Other hedge funds have also recently added to or reduced their stakes in the company. Torren Management LLC acquired a new position in shares of Molina Healthcare in the 4th quarter worth approximately $26,000. Miller Global Investments LLC acquired a new stake in Molina Healthcare during the 4th quarter valued at $27,000. MUFG Securities EMEA plc acquired a new stake in Molina Healthcare during the 2nd quarter valued at $48,000. Cromwell Holdings LLC increased its holdings in Molina Healthcare by 211.9% during the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock valued at $32,000 after purchasing an additional 125 shares in the last quarter. Finally, Quarry LP acquired a new stake in Molina Healthcare during the 4th quarter valued at $32,000. Institutional investors own 98.50% of the company’s stock.

Insider Buying and Selling at Molina Healthcare

In other news, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the transaction, the insider directly owned 67,175 shares in the company, valued at $12,502,611. This trade represents a 20.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the transaction, the chief accounting officer owned 12,815 shares in the company, valued at $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is owned by company insiders.

Molina Healthcare Stock Up 0.1%

Shares of MOH opened at $200.55 on Monday. The firm has a market capitalization of $10.45 billion, a price-to-earnings ratio of 59.33 and a beta of 0.80. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63. The business’s fifty day moving average price is $174.79 and its two-hundred day moving average price is $164.63. Molina Healthcare, Inc has a 52 week low of $121.06 and a 52 week high of $311.52.

Molina Healthcare (NYSE:MOHGet Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The business had revenue of $10.80 billion for the quarter, compared to analyst estimates of $10.91 billion. During the same period last year, the company earned $6.08 EPS. The firm’s revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, analysts predict that Molina Healthcare, Inc will post 5.23 earnings per share for the current year.

Wall Street Analyst Weigh In

MOH has been the subject of a number of recent analyst reports. Cantor Fitzgerald raised their price target on Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Barclays raised their price target on Molina Healthcare from $161.00 to $199.00 and gave the company an “underweight” rating in a report on Tuesday, May 26th. Wells Fargo & Company raised their price target on Molina Healthcare from $141.00 to $159.00 and gave the company an “equal weight” rating in a report on Monday, April 27th. Zacks Research raised Molina Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Finally, Morgan Stanley raised their price target on Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a report on Thursday, June 4th. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $182.73.

Get Our Latest Stock Analysis on Molina Healthcare

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

Featured Stories

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOHFree Report).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.